NCT02348333 - Repeated Dose Phase I Study of FYU-981 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

December 31, 2013

Conditions

Healthy

Interventions

DRUG

FYU-981, (Oral daily dosing for 7 days)

Subjects randomized to the FYU-981 arm receive active drug, FYU-981.

DRUG

Placebo, (Oral daily dosing for 7 days)

Subjects randomized to the placebo arm receive placebo.

Trial Locations (1)

Japan, Tokyo